Business Standard

Jagsonpal Pharmaceuticals standalone net profit rises 31.03% in the December 2019 quarter

Image

Capital Market

Sales rise 0.29% to Rs 42.01 crore

Net profit of Jagsonpal Pharmaceuticals rose 31.03% to Rs 2.28 crore in the quarter ended December 2019 as against Rs 1.74 crore during the previous quarter ended December 2018. Sales rose 0.29% to Rs 42.01 crore in the quarter ended December 2019 as against Rs 41.89 crore during the previous quarter ended December 2018. ParticularsQuarter EndedDec. 2019Dec. 2018% Var.Sales42.0141.89 0 OPM %6.095.23 -PBDT3.112.37 31 PBT2.852.14 33 NP2.281.74 31

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 14 2020 | 12:49 PM IST

Explore News